Page last updated: 2024-10-26

etodolac and Hypesthesia

etodolac has been researched along with Hypesthesia in 1 studies

Etodolac: A non-steroidal anti-inflammatory agent and cyclooxygenase-2 (COX-2) inhibitor with potent analgesic and anti-arthritic properties. It has been shown to be effective in the treatment of OSTEOARTHRITIS; RHEUMATOID ARTHRITIS; ANKYLOSING SPONDYLITIS; and in the alleviation of postoperative pain (PAIN, POSTOPERATIVE).
etodolac : A monocarboxylic acid that is acetic acid in which one of the methyl hydrogens is substituted by a 1,8-diethyl-1,3,4,9-tetrahydropyrano[3,4-b]indol-1-yl moiety. A preferential inhibitor of cyclo-oxygenase 2 and non-steroidal anti-inflammatory, it is used for the treatment of rheumatoid arthritis and osteoarthritis, and for the alleviation of postoperative pain. Administered as the racemate, only the (S)-enantiomer is active.

Hypesthesia: Absent or reduced sensitivity to cutaneous stimulation.

Research Excerpts

ExcerptRelevanceReference
"To examine the effect of limaprost, an oral prostaglandin (PG) E1 derivative, on health-related quality of life (HRQOL) in patients with symptomatic lumbar spinal stenosis (LSS), compared to etodolac, a NSAID."5.14The efficacy of prostaglandin E1 derivative in patients with lumbar spinal stenosis. ( Anamizu, Y; Hoshi, K; Kishimoto, J; Kobayashi, A; Kunogi, J; Matsudaira, K; Nakamura, K; Seichi, A; Takeshita, K; Yamazaki, T, 2009)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Matsudaira, K1
Seichi, A1
Kunogi, J1
Yamazaki, T1
Kobayashi, A1
Anamizu, Y1
Kishimoto, J1
Hoshi, K1
Takeshita, K1
Nakamura, K1

Trials

1 trial available for etodolac and Hypesthesia

ArticleYear
The efficacy of prostaglandin E1 derivative in patients with lumbar spinal stenosis.
    Spine, 2009, Jan-15, Volume: 34, Issue:2

    Topics: Activities of Daily Living; Aged; Aged, 80 and over; Alprostadil; Anti-Inflammatory Agents, Non-Ster

2009